Global Molecular Biology Enzymes and Kits & Reagents Market Application, Growth Rate & Top Companies Analysis

NEXT STORY
Acino acquires selected Aspen brands in South Africa
PREV STORY
Dupixent® (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Tuloksia darolutamidista esitetty Yhdysvaltain kliinisen onkologian yhdistyksen (ASCO) vuosikokouksessa 2019

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Introduces Vision 3×3: A Strategic Roadmap Through 2025 to Achieve Sustainable Growth Using Multiple Approaches

COPENHAGEN, Denmark, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a ...

author_avatar
NASDAQ Market News

miRagen Therapeutics to Present New Clinical Trial Data for MRG-106, an Oligonucleotide Therapeutic Targeting microRNA-155, at the American Society of Clinical Oncology Annual Meeting

BOULDER, Colo., May 17, 2017 (GLOBE NEWSWIRE) -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage ...

author_avatar
NASDAQ Market News